The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMBRX BIOPHARMA INC | COM | 641871108 | 44,561,232 | 3,129,300 | SH | SOLE | 3,129,300 | 0 | 0 | |||
| ARS PHARMACEUTICALS INC | COM | 82835W108 | 10,466,959 | 1,910,029 | SH | SOLE | 1,910,029 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 69,792,748 | 1,695,645 | SH | SOLE | 1,695,645 | 0 | 0 | |||
| CARGO THERAPEUTICS INC | COM | 14179K101 | 61,173,921 | 2,642,502 | SH | SOLE | 2,642,502 | 0 | 0 | |||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 12,443,468 | 1,221,145 | SH | SOLE | 1,221,145 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 13,869,719 | 5,978,327 | SH | SOLE | 5,978,327 | 0 | 0 | |||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 39,428,569 | 4,285,714 | SH | SOLE | 4,285,714 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 14,823,963 | 1,346,409 | SH | SOLE | 1,346,409 | 0 | 0 | |||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 180,590,503 | 6,296,740 | SH | SOLE | 6,296,740 | 0 | 0 | |||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 54,786,402 | 5,533,980 | SH | SOLE | 5,533,980 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 34,882,361 | 2,518,582 | SH | SOLE | 2,518,582 | 0 | 0 | |||